| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lars Michels, Muthuraman Muthuraman, Abdul R Anwar, Spyros Kollias, Sandra E Leh, Florian Riese, Paul G Unschuld, Michael Siniatchkin, Anton F Gietl, Christoph Hoc. Changes of Functional and Directed Resting-State Connectivity Are Associated with Neuronal Oscillations, ApoE Genotype and Amyloid Deposition in Mild Cognitive Impairment. Frontiers in aging neuroscience. vol 9. 2020-09-30. PMID:29081745. |
yet, these measures have rarely been assessed in parallel in the context of mild cognitive impairment (mci) and furthermore it has not been examined if they are related to risk factors of alzheimer's disease (ad) such as amyloid deposition and apolipoprotein ε4 (apoe) allele occurrence. |
2020-09-30 |
2023-08-13 |
human |
| Stefany Montufar, Cristian Calero, Rodrigo Vinueza, Patricio Correa, Andrea Carrera-Gonzalez, Franklin Villegas, Germania Moreta, Rosario Parede. Association between the APOE International journal of Alzheimer's disease. vol 2017. 2020-09-30. PMID:29348964. |
association between the apoe alzheimer's disease (ad) is the most common neurodegenerative disease. |
2020-09-30 |
2023-08-13 |
Not clear |
| Qiong Ding, Kitora Tanigawa, Jun Kaneko, Mamoru Totsuka, Yoshinori Katakura, Etsuko Imabayashi, Hiroshi Matsuda, Tatsuhiro Hisatsun. Anserine/Carnosine Supplementation Preserves Blood Flow in the Prefrontal Brain of Elderly People Carrying APOE e4. Aging and disease. vol 9. issue 3. 2020-09-30. PMID:29896423. |
here, we conducted a sub-analysis of mri data and test scores from the same rct to determine whether anserine/carnosine supplementation specifically benefits elderly people carrying the apoe e4 allele, which is a risk gene for accelerated brain aging and for the onset of alzheimer's disease. |
2020-09-30 |
2023-08-13 |
human |
| Stella E Panos, Charles H Hinkin, Elyse J Singer, April D Thames, Sapna M Patel, Janet S Sinsheimer, A C Del Re, Benjamin B Gelman, Susan Morgello, David J Moore, Andrew J Levin. Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity. Neurobehavioral HIV medicine. vol 5. 2020-09-29. PMID:26617462. |
the apolipoprotein-e (apoe) ε4 allele is a risk factor for vascular dementia and alzheimer's disease. |
2020-09-29 |
2023-08-13 |
human |
| Lijun Wang, Xiaoli Pan, Guoqiang Fei, Changpeng Wang, Wenbin Wan, Shaoming Sang, Hui Wang, Zhiliang Wang, Chunjiu Zhon. Decreased Function of Delayed Recall in Non-demented Elderly Subjects With Apolipoprotein E ε4 Allele. Frontiers in aging neuroscience. vol 11. 2020-09-29. PMID:30983990. |
apolipoprotein e (apoe) is the major genetic risk factor for late-onset alzheimer's disease (ad). |
2020-09-29 |
2023-08-13 |
human |
| Steven Lehrer, Peter H Rheinstei. Alzheimer's Disease Susceptibility Genes in Malignant Breast Tumors. Cancer translational medicine. vol 5. issue 2. 2020-09-29. PMID:31453369. |
we have analyzed the expression of apoe and the next 23-ranked alzheimer's disease (ad) susceptibility genes in malignant breast tumors. |
2020-09-29 |
2023-08-13 |
Not clear |
| Kyriakos E Kypreos, Eleni A Karavia, Caterina Constantinou, Aikaterini Hatziri, Christina Kalogeropoulou, Eva Xepapadaki, Evangelia Zvintzo. Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perception. Journal of biomedical research. 2020-09-28. PMID:29770778. |
numerous epidemiological studies suggest a key role of peripherally expressed apoe in the development and progression of coronary heart disease while brain apoe has been associated with dementia and alzheimer's disease. |
2020-09-28 |
2023-08-13 |
mouse |
| Lígia Ramos Dos Santos, Jucimara Ferreira Figueiredo Almeida, Lúcia Helena Sagrillo Pimassoni, Renato Lírio Morelato, Flavia de Paul. The combined risk effect among BIN1, CLU, and APOE genes in Alzheimer's disease. Genetics and molecular biology. vol 43. issue 1. 2020-09-28. PMID:31469155. |
the combined risk effect among bin1, clu, and apoe genes in alzheimer's disease. |
2020-09-28 |
2023-08-13 |
Not clear |
| Rebecca Piccarducci, Simona Daniele, Jonathan Fusi, Lucia Chico, Filippo Baldacci, Gabriele Siciliano, Ubaldo Bonuccelli, Ferdinando Franzoni, Claudia Martin. Impact of ApoE Polymorphism and Physical Activity on Plasma Antioxidant Capability and Erythrocyte Membranes. Antioxidants (Basel, Switzerland). vol 8. issue 11. 2020-09-28. PMID:31717561. |
the allele epsilon 4 (ε4) of apolipoprotein e (apoe) is the strongest genetic risk factor for alzheimer's disease (ad). |
2020-09-28 |
2023-08-13 |
human |
| Sander Lamballais, Ryan L Muetzel, Mohammad Arfan Ikram, Henning Tiemeier, Meike W Vernooij, Tonya White, Hieab H H Adam. Genetic Burden for Late-Life Neurodegenerative Disease and Its Association With Early-Life Lipids, Brain, Behavior, and Cognition. Frontiers in psychiatry. vol 11. 2020-09-28. PMID:32116848. |
previous studies have shown evidence for plausible links of apolipoprotein e (apoe), the most important genetic marker for alzheimer's disease, with early-life cognition and neuroimaging markers. |
2020-09-28 |
2023-08-13 |
Not clear |
| Chunhua Zhang, Min Kong, Hongchun Wei, Hua Zhang, Guozhao Ma, Maowen B. The effect of ApoE ε 4 on clinical and structural MRI markers in prodromal Alzheimer's disease. Quantitative imaging in medicine and surgery. vol 10. issue 2. 2020-09-28. PMID:32190571. |
the effect of apoe ε 4 on clinical and structural mri markers in prodromal alzheimer's disease. |
2020-09-28 |
2023-08-13 |
human |
| Chunhua Zhang, Min Kong, Hongchun Wei, Hua Zhang, Guozhao Ma, Maowen B. The effect of ApoE ε 4 on clinical and structural MRI markers in prodromal Alzheimer's disease. Quantitative imaging in medicine and surgery. vol 10. issue 2. 2020-09-28. PMID:32190571. |
apolipoprotein e (apoe) ε 4 has been identified as the strongest genetic risk factor for alzheimer's disease (ad). |
2020-09-28 |
2023-08-13 |
human |
| Lijun Wang, Miao Zhang, Qian Wang, Xianguo Jiang, Kunyi Li, Jun Li. APOE ε4 Allele Is Associated with Elevated Levels of CSF VILIP-1 in Preclinical Alzheimer's Disease. Neuropsychiatric disease and treatment. vol 16. 2020-09-28. PMID:32308396. |
apoe ε4 allele is associated with elevated levels of csf vilip-1 in preclinical alzheimer's disease. |
2020-09-28 |
2023-08-13 |
Not clear |
| Jung-Ju Lee, Youngki Choi, Soie Chung, Dae Hyun Yoon, Seung Ho Choi, Sung-Min Kang, David Seo, Kyung-Il Par. Association of Plasma Oligomerized Beta Amyloid with Neurocognitive Battery Using Korean Version of Consortium to Establish a Registry for Alzheimer's Disease in Health Screening Population. Diagnostics (Basel, Switzerland). vol 10. issue 4. 2020-09-28. PMID:32326061. |
participants performed the korean version of the consortium to establish a registry for alzheimer's disease (cerad-k), the clinical dementia rating (cdr), plasma oligomeric amyloid-β (oaβ) level tests, routine blood tests, apoe genotype, and brain mri. |
2020-09-28 |
2023-08-13 |
human |
| Diana C Oviedo, Hector Lezcano, Ambar R Perez, Alcibiades E Villarreal, Maria B Carreira, Baltasar Isaza, Lavinia Wesley, Shantal A Grajales, Sara Fernandez, Ana Frank, Gabrielle B Britto. Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer's disease. AIMS neuroscience. vol 5. issue 2. 2020-09-28. PMID:32341958. |
vascular pathology and genetic markers such as apolipoprotein e allele ε4 (apoe ε4) are risk factors for the progression from mild cognitive impairment (mci) to alzheimer's disease (ad). |
2020-09-28 |
2023-08-13 |
Not clear |
| Richard Andrew Burns, Shea Andrews, Nicolas Cherbuin, Kaarin Jane Anste. Role of apolipoprotein E epsilon 4 ( BJPsych open. vol 6. issue 3. 2020-09-28. PMID:32381152. |
role of apolipoprotein e epsilon 4 ( the apolipoprotein e ε4 allele (apoe*ε4) is indicated as a risk for alzheimer's disease and other age-related diseases. |
2020-09-28 |
2023-08-13 |
Not clear |
| Inés López-Cuenca, Rosa de de Hoz, Elena Salobrar-García, Lorena Elvira-Hurtado, Pilar Rojas, José A Fernández-Albarral, Ana Barabash, Juan J Salazar, Ana I Ramírez, José M Ramíre. Macular Thickness Decrease in Asymptomatic Subjects at High Genetic Risk of Developing Alzheimer's Disease: An OCT Study. Journal of clinical medicine. vol 9. issue 6. 2020-09-28. PMID:32503282. |
thirty-five subjects with a family history of alzheimer disease (ad) (fh+) and apoe ɛ4 carriers and 29 age-matched control subjects without a family history of ad (fh-) and apoe ɛ4 non-carriers were included. |
2020-09-28 |
2023-08-13 |
human |
| Yubraj Gupta, Ji-In Kim, Byeong Chae Kim, Goo-Rak Kwo. Classification and Graphical Analysis of Alzheimer's Disease and Its Prodromal Stage Using Multimodal Features From Structural, Diffusion, and Functional Neuroimaging Data and the APOE Genotype. Frontiers in aging neuroscience. vol 12. 2020-09-28. PMID:32848713. |
classification and graphical analysis of alzheimer's disease and its prodromal stage using multimodal features from structural, diffusion, and functional neuroimaging data and the apoe genotype. |
2020-09-28 |
2023-08-13 |
human |
| Junxiang Yin, Eric M Reiman, Thomas G Beach, Geidy E Serrano, Marwan N Sabbagh, Megan Nielsen, Richard J Caselli, Jiong Sh. Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology. vol 94. issue 23. 2020-09-24. PMID:32457210. |
effect of apoe isoforms on mitochondria in alzheimer disease. |
2020-09-24 |
2023-08-13 |
Not clear |
| Junxiang Yin, Eric M Reiman, Thomas G Beach, Geidy E Serrano, Marwan N Sabbagh, Megan Nielsen, Richard J Caselli, Jiong Sh. Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology. vol 94. issue 23. 2020-09-24. PMID:32457210. |
to test the hypothesis that apoe isoforms affect mitochondrial structure and function that are related to cognitive impairment in alzheimer disease (ad), we systematically investigated the effects of apoe isoforms on mitochondrial biogenesis and dynamics, oxidative stress, synapses, and cognitive performance in ad. |
2020-09-24 |
2023-08-13 |
Not clear |